ClinicalTrialsFinder

HR+/HER2- Early Breast Cancer Clinical Trials

1 recruiting

Showing 1–2 of 2 trials

Recruiting
Phase 2

A Study on the Use of Fluzoparib Combined With Chemotherapy for Neoadjuvant Treatment of HRD-positive, HR+/HER2- Breast Cancer

HR+/HER2- Early Breast Cancer
Xijing Hospital28 enrolled1 locationNCT07162051
Recruiting

RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Early Breast Cancer in Saudi Arabia

HR+/HER2- Early Breast Cancer
Novartis Pharmaceuticals177 enrolled2 locationsNCT06797531